Skip to main content
RedHill Biopharma Ltd. logo

RedHill Biopharma Ltd. — Investor Relations & Filings

Ticker · RDHL ISIN · US7574681034 LEI · 52990034U7FZBKRAOE32 US Manufacturing
Open in API
Filings indexed 993 across all filing types
Latest filing 2016-02-16 Major Shareholding Noti…
Country IL Israel
Listing US RDHL

About RedHill Biopharma Ltd.

https://www.redhillbio.com/

RedHill Biopharma is a specialty biopharmaceutical company focused on the development and commercialization of proprietary, orally-administered, small molecule drugs. The company's primary therapeutic areas of focus are gastrointestinal (GI) diseases, infectious diseases, and oncology. Its key commercial product is Talicia® for the treatment of Helicobacter pylori (H. pylori) infection. RedHill's late-stage clinical development pipeline includes several drug candidates. Among these are Opaganib, a broad-acting, host-directed antiviral and anti-inflammatory agent; RHB-204 for pulmonary nontuberculous mycobacteria (NTM) disease; and RHB-107 (upamostat), an oral serine protease inhibitor. A significant part of its strategy involves developing its assets for pandemic preparedness and as medical countermeasures, emphasizing therapies with viral mutation-resistant properties suitable for stockpiling.

Recent filings

Filing Released Lang Actions
SCHEDULE 13G/A
Major Shareholding Notification
2016-02-16 English
Major Shareholding Notification 2016
Major Shareholding Notification
2016-02-11 English
SCHEDULE 13G/A
Major Shareholding Notification
2016-02-11 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filing by a foreign private issuer, RedHill Biopharma Ltd., submitted to the SEC. It includes a press release about a successful pharmacokinetic study and submission of a study protocol to the FDA. Form 6-K is used by foreign private issuers to report material information that is not required to be filed on Forms 20-F or 40-F. The document is short (1936 characters) and primarily serves as a regulatory announcement of a press release rather than a detailed financial report or earnings release. It does not contain comprehensive financial statements or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and filings that do not fit other specific categories.
2016-02-11 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, RedHill Biopharma Ltd., pursuant to SEC rules for periodic reports by foreign companies. It includes a press release about a patent allowance related to a Phase III clinical program. The document is short (1932 characters) and primarily serves as a regulatory announcement rather than a detailed financial or management report. It does not contain financial statements, management discussion, or detailed disclosures typical of annual or interim reports. It also does not fit into categories like earnings release, capital update, or governance information. Given the nature and length, this filing best fits the Regulatory Filings (RNS) category, which is a fallback for miscellaneous regulatory announcements and filings that do not fit other specific categories.
2016-02-10 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filing by RedHill Biopharma Ltd., which is a report of a foreign private issuer pursuant to SEC rules. It includes a press release titled 'RedHill Biopharma Issues Letter to Shareholders' but does not contain detailed financial statements or substantive financial data. The document length is 1861 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. The text indicates it is incorporated by reference into other registration statements but does not itself present financial results or detailed management discussion. Therefore, this filing is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2016-02-09 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.